NCT01711606View on ClinicalTrials.gov

EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes

TerminatedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Fragile-X Syndrome
Trial Locations (1)

Unknown

Novartis Investigative site, Nuremberg

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT01711606 - EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes | Biotech Hunter | Biotech Hunter